Ensemble Discovery is developing novel classes of therapeutics (Ensemblins™) and diagnostics using its proprietary chemistry platforms.

Our pharmaceutical business is developing a new class of therapeutics -- Ensemblins™ --which combine the advantages of oral small molecule medicines with the power of biologicals.

Our diagnostic business is developing assays of protein functionality, for use in guiding personalized oncology therapy.